Unclaimed Scholar Profile
Are you Sorachai Nitayaphan? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of Cape TownASIDASID-4113-1094-3549 orcid.org/0000-0001-6935-1405
Sorachai Nitayaphan
University of Cape Town•South Africa
Faculty researcher at University of Cape Town (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#HIV Research and Treatment#HIV/AIDS Research and Interventions#SARS-CoV-2 and COVID-19 Research#Monoclonal and Polyclonal Antibodies Research
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 13,674 | 6,564 |
| h-index | 47 | 35 |
| i10-index | 110 | 77 |
Annual Citation Growth
Verified Citations / Year0
2020656
2021+40%919
2022+29%1.2k
2023+33%1.6k
2024-8%1.4k
2025-45%788
2026Scholarship Distribution & Proportions177 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (11,213) • 18% Global Research Impact (2,461)
177 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (177)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Published in New England Journal of Medicine•2009
DOI: 10.1056/nejmoa0908492 Verified Peer-Reviewed
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
DOI: 10.1056/nejmoa1113425 Verified Peer-Reviewed
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Published in Science Translational Medicine•2014
DOI: 10.1126/scitranslmed.3007730 Verified Peer-Reviewed
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Published in Nature•2012
DOI: 10.1038/nature11519 Verified Peer-Reviewed
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Published in Science Translational Medicine•2014
DOI: 10.1126/scitranslmed.3007736 Verified Peer-Reviewed
Showing 1 – 5 of 177 publications
1 / 36